← Open Payments lookup

KEVIN SNYDER: Open Payments

NPI 1174583959 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,092 in 51 payments from 13 companies in 2025. Trend: 2023 $1,065 · 2024 $872 · 2025 $1,092

Food & beverage: $1,092
CompanyPaymentsAmount
ABBVIE INC.16$388
Novo Nordisk Inc7$194
Orexo US, Inc.6$99
Amgen Inc.4$68
GlaxoSmithKline, LLC.3$64
Lilly USA, LLC3$55
Indivior Inc.2$49
Exact Sciences Corporation2$38
PFIZER INC.2$36
AstraZeneca Pharmaceuticals LP2$33

Products named: QULIPTA, Ozempic, Zubsolv, SHINGRIX, Rybelsus, VRAYLAR, MOUNJARO, EVENITY.

Industry payments across MD — which companies pay providers there.